Syndrome of inappropriate antidiuretic hormone secretion (SIADH): optimal management

G Mentrasti, L Scortichini, M Torniai… - … and clinical risk …, 2020 - Taylor & Francis
Hyponatremia, defined as serum sodium concentration< 135 mEq/l, is the most common
electrolyte balance disorder in clinical practice. Many causes are listed, but syndrome of …

Hyponatremia and cancer: from bedside to benchside

B Fibbi, G Marroncini, L Naldi, C Anceschi, A Errico… - Cancers, 2023 - mdpi.com
Simple Summary This review article is focused on hyponatremia in cancer patients.
Hyponatremia is the most common electrolyte disorder in these patients and there is …

[HTML][HTML] Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy

R Berardi, M Santoni, T Newsom-Davis, M Caramanti… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Hyponatremia normalization as an independent prognostic factor in patients with advanced
non-small cell lung cancer treated with first-line therapy - PMC Back to Top Skip to main content …

Managing hyponatremia in lung cancer: latest evidence and clinical implications

I Fiordoliva, T Meletani, MG Baleani… - … in medical oncology, 2017 - journals.sagepub.com
Hyponatremia is the most common electrolyte disorder in lung cancer patients. This
condition may be related to many causes including incidental medications, concurrent …

Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis

L Cantini, F Merloni, S Rinaldi, E Lenci… - Critical reviews in …, 2020 - Elsevier
Background Aim of this meta-analysis was to determine the relative risk (RR) of electrolyte
disorders (EDs) in advanced non-small cell lung cancer (aNSCLC) patients treated with …

Hyponatremia Promotes Cancer Growth in a Murine Xenograft Model of Neuroblastoma

G Marroncini, L Naldi, B Fibbi, A Errico… - International Journal of …, 2023 - mdpi.com
In cancer patients, hyponatremia is detected in about 40% of cases at hospital admission
and has been associated to a worse outcome. We have previously observed that cancer …

[HTML][HTML] Laboratory parameters are possible prognostic markers in patients with advanced-stage NSCLC treated with bevacizumab plus chemotherapy

M Svaton, J Blazek, G Krakorova, M Buresova… - Journal of …, 2021 - ncbi.nlm.nih.gov
Purpose: To investigate potential associations between selected laboratory markers (CRP,
LDH, albumin, sodium, hemoglobin, neutrophils, and neutrophils/lymphocytes ratio [NLR]) …

Hyponatremia in lung cancer: Incidence and prognostic value in a Danish population-based cohort study

B Sandfeld-Paulsen, N Aggerholm-Pedersen… - Lung Cancer, 2021 - Elsevier
Objectives Hyponatremia is a common electrolyte disorder in lung cancer patients,
especially in patients with small-cell lung cancer (SCLC). It has been proposed as a …

Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study

R Berardi, C Mastroianni, G Lo Russo… - … in medical oncology, 2019 - journals.sagepub.com
Background: Hyponatremia in cancer patients is often caused by the syndrome of
inappropriate antidiuretic hormone secretion (SIADH). The aim of this observational …

Prevalence and prognostic significance of hyponatremia in patients with lung cancer: systematic review and meta-analysis

E Bartalis, M Gergics, B Tinusz, M Földi, S Kiss… - Frontiers in …, 2021 - frontiersin.org
Background: The prevalence of hyponatremia is highly variable among patients with lung
cancer. However, its prevalence and prognostic significance in subgroups of patients with …